Pulp Disease, Dental Clinical Trial
Official title:
Clinical and Radiographic Evaluation of Diode and Er:Cr;YSGG Lasers as an Alternative to Formocresol and Sodium Hypochlorite for Pulpotomy Technique in Primary Molars - Randomized Controlled Clinical Trial
The goal of this clinical trial is to evaluate the dental lasers as an alternative of chemical medicaments used in the pulpotomy procedures. The main question it aims to answer is: • Lasers pulpotomies are a viable alternative to the standard Formocresol and Sodium Hypochlorite medicaments. All participants groups (Formocresol, Sodium Hypochlorite, Diode and Er:Cr;YSGG lasers) for pulpotomy procedure will follow the same clinical protocol, except for the techniques that will be used for hemostasis of the pulpotomies which either will be achieved by Formocresol or Sodium Hypochlorite solutions or by Diode or Erbium lasers.
All the selected treatment groups (Formocresol, Sodium Hypochlorite, Diode and Er:Cr;YSGG lasers) will follow the same clinical protocol, except for the techniques that will be used for hemostasis of the pulpotomies: 1. Using 2 percent lidocaine with 1: 100,000 epinephrine as a local anesthetic. 2. Isolation of the teeth with a rubber dam. 3. Using a diamond round #440 bur in a high-speed hand piece with water cooling to eliminate caries and expose pulp chambers. 4. Using a spoon excavator to remove the coronal pulp. 5. Achieving the hemostasis by: I. In first group (Group A): using a 1:5 dilution of Buckley's FC solution. A sterile cotton pellet will be moistened with a 1:5 concentration formocresol and it will be placed on the pulp stumps for 5 minutes for achieving hemostasis before being covered with MTA. If hemostasis will not be achieved after 5 minutes, it will presume that the pulp tissue in the canal was infected, and the tooth will be removed from the research. II. In the second group (Group B): using 3% NaOCl. A sterile cotton pellet will be moistened with a 3% NaOCl and it will be placed on the pulp chamber for 5 minutes for achieving hemostasis before being covered with MTA. III. In the third group (Group C): In this group hemostasis will be achieved by exposure to diode laser of 940 nm. The laser energy will be introduced into the canal orifice through a 300 µm optical fiber at 2 W, in a contact mode with continuous mode CW (According to the user manual) for 1 second at each orifice for three times to achieve complete hemostasis. During laser application patients, operator and assistant will use protective eye shields according to the safety measures of the device user manual. IV. In the fourth group (Group D): Irradiation of the floor of the pulp chamber with Er,Cr:YSGG laser 2790 nm ) at a Power of 1.5 w, Frequency of 50 Hz, mode S (soft tissue mode) , 20%air and no water with a gold handpiece and Tip type MZ6, for 10 sec.(According to the manufacturer manual iPlus™ software copyright ©2016 BIOLASE, Inc.). In which a fixed char layer should be formed over the pulpal tissue of the canals orifices. During laser application patients, operator and assistant will use protective eye shields according to the safety measures of the device user manual. 1. Then covering the surface with a 2 mm layer of MTA 2. The final restoration will be completed in all the four groups, stainless steel crown will be placed as the final restorative material with a well-fitting marginal adaption and glass ionomer cement(GC company). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06467890 -
Knowledge of Vital Pulp Therapy in Permanent Teeth After Educational Programme: A Before and After Study
|
||
Not yet recruiting |
NCT05981352 -
Evaluation of Different Materials in Pulpotomy of Primary Molars
|
N/A | |
Recruiting |
NCT06227390 -
Clinical and Radiographic Outcomes of Partial Pulpotomy Procedure in Primary Molars Utilizing Different Capping Materials and Different Restorative Methods
|
N/A | |
Completed |
NCT06398327 -
Efficacy Of Proinflammatory Cytokines in The Primary Molar Pulpotomy
|
N/A | |
Recruiting |
NCT03883295 -
Evaluation of Clinical and Radiological Success of Vital Amputation Treatment
|
N/A | |
Active, not recruiting |
NCT03580135 -
Postoperative Pain Evaluation of Mineral Trioxide Aggregate and Propolis After Pulpotomy in Carious Primary Molars
|
Phase 2 | |
Recruiting |
NCT03410134 -
Assessment of Vital Pulp Therapy in Permanent Molars
|
N/A | |
Recruiting |
NCT04793477 -
Effectiveness of Rotating System and Single File Reciprocating System in Temporal Molars
|
N/A | |
Completed |
NCT04274920 -
Dentin Bridge Formation After Indirect Pulp Capping With Bioactive Glass Incorporated in Resin Composite and Its Adhesive in Comparison With Light Cured Calcium Hydroxide
|
N/A | |
Not yet recruiting |
NCT05839548 -
Articaine Efficacy and Safety for 3 Years Old Children
|
Phase 3 | |
Active, not recruiting |
NCT05912907 -
Potassium Nitrate in Polycarboxylate as a Direct Pulp Capping
|
N/A | |
Completed |
NCT05633537 -
Clinical & Radiographic Evaluation of Zinc Oxide-Ozonated Oil as a New Primary Root Canal Filling
|
N/A | |
Completed |
NCT06110494 -
A New Clinical Use of Ferumoxytol Nanoparticles: An Antibiofilm Treatment
|
Phase 4 | |
Completed |
NCT03542019 -
Survival of Endocrowns Made From Different Ceramics
|
N/A | |
Not yet recruiting |
NCT03368391 -
: Pulpal Blood Flow With the Use of Intra-nasal Anesthetic
|
Phase 4 | |
Recruiting |
NCT06196515 -
Anti-bacterial Potential of Nano Calcium Hydroxide as an Intracanal Medication
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT04650113 -
Clinical and Radiographic Assessment of Partial and Complete Pulpotomy in Primary Molars Using MTA
|
Phase 1/Phase 2 | |
Completed |
NCT06129643 -
Post-operative Pain After Laser Root Canal Treatment of Necrotic Teeth With Apical Periodontitis
|
Phase 2 | |
Recruiting |
NCT06207253 -
The Antimicrobial Potential of Diclofenac Sodium as an Intracanal Medicament
|
Phase 2/Phase 3 | |
Completed |
NCT03582319 -
Clinical and Radiographic Evaluation of Biodentine Versus Formocresol
|
N/A |